These observations are consistent with work showing that blood levels of soluble IL1-ra protein increased with GA treatment in MS patients and EAE mice, and that levels of soluble IL1-ra increased with GA treatment in human monocytes stimulated with LPS or activated by T-cell contact6. This evidence concerns the gene IL1RN and myeloid sarcoma.